News

“Targets for Tomorrow” Workshop at GRC in Italy July 2013

23 Jun 2013
by Working Group
Announcements Early Drug Development Events
drug discovery gordon research conferences grc innovations r&d targets wgnd

We invite you to join us for the “Targets for Tomorrow” satellite workshop hosted by the WGND Biology/Targets Subgroup on Monday, July 22, 2013 from 2 p.m. to 4:30 p.m. at the Renaissance Tuscany Il Ciocco Resort, Lucca (Barga), Italy. The workshop is held in conjunction with the Gordon Conference on TB Drug Development (July 21-26). The objectives of the meeting are to:

  • Allow key entities involved strategically in TB drug discovery to present their views of the needs, directions and targets for tomorrow to the research community
  • Discuss the puzzling finding of ‘promiscuous targets’
  • Set a priority list of what constitutes good targets and what does not to develop a universal “go/no go” checklist for targets
“Targets For Tomorrow” Satellite Workshop
AGENDA
Workshop Chair: Thomas Dick
2:00 p.m.-3:15pm: Needs & directions in TB drug discovery–Leader: Petros KarakousisSession Speakers:
  • Barbara Laughon (NIAID/NIH)
  • Ken Duncan (Bill & Melinda Gates Foundation)
  • Anna Upton (TB Alliance)
  • Alfonso Mendoza-Losana (GlaxoSmithKline)
  • Petros Karakousis (Johns Hopkins)
3:15-3:30pm: Break
3:30-4:30pm: ‘Promiscuous targets’–Leader: Tanya ParishDiscussion Topics:
  • What makes a good target—Speaker: Bavesh Kana
  • Results from current target ID efforts– Speaker: Dirk Schnappinger
  • Are promiscuous targets good or bad– Speaker: TBD
  • Best approaches to target-based screening—Speaker: Helena Boshoff

Light refreshments will be served.

If you plan on attending the satellite workshop, please RSVP by e-mailing wgnd@newtbdrugs.org.

More News
19 Mar 2024

Most Robust TB Drug Pipeline in History

For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023

New Tools Summit in Paris this November

The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022

PAN-TB Collaboration Announces Novel TB Drug Regimens Trial

The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...